Ok, the shills at The Oxford Club are playing guess the company again. And they're going to use this technology to scan containers coming in the ports. So this is also a terrorism play. At least according to The Oxford Club.
A small U.S. company - already raking in revenues of more than $800 million and showing net profits of over $100 million - will post explosive gains in both sales and profits in the next few weeks. Those who own the stock are - in effect - holding a winning lottery ticket.
1.3 million Americans are diagnosed with cancer each year. And, sadly, more than 1,500 people in the U.S. die from it every day.
But one company is doing something about it. No... not a biotech company hoping to make it through Phase III trials, but rather a medical technology firm whose products are actually killing cancer tumors right now in hundreds of hospitals around the world.
How? With a new cutting-edge technology only recently unveiled. And investors who hold this stock are ready to collect the payoff of a lifetime.
Just listen to what the experts have to say:
Dr. Patrick Swift, medical director at the Alta Bates Comprehensive Cancer Center in Berkeley, California says 'a quarter or possibly a third of our cancer patient population will soon be undergoing this treatment.'
Dr. James Cox of the University of Texas M.D. Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology. And, he adds, 'it is very much a part of our future.'
And Dr. Ted Lawrence, Professor of Oncology at the University of Michigan, says this breakthrough technology has opened up nothing less than 'extraordinary possibilities.'
Yet most folks on Wall Street are still unaware of this story. Few investment firms even follow the stock.
But it's just a matter of time before the national media seizes on what's happening here... and turns this unknown company into a household name. Then millions of individual investors - and their fund managers - will begin shoveling money into the stock.
When the public finally understands this company is actually killing cancer tumors right now with a success rate as high as 96%, shares of this company will simply ignite. And, quite frankly, there is no calculating how high the stock will go.
Even the U.S. government has given this new technology its blessing. How can we be sure? Because the company's cancer treatments have just become eligible for both Medicare and Medicaid reimbursement.
Before long, cancer patients the world over will be demanding this medical treatment. And that will spark interest in the stock by investors all over the globe. .......... It goes on and on from here, but you get the idea.
Market Data 
Markets 
AI
